#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleomorphic liposarcoma Congenital myopathy Fontan procedure Transitional cell cancer of the renal pelvis and ureter Chronic graft versus host disease Pneumonia Chorioretinitis Monogenic diabetes Adult T-cell lymphoma/leukaemia refractory Liposarcoma metastatic Pyoderma gangrenosum Marginal zone lymphoma Follicular lymphoma stage I Allogenic stem cell transplantation Erdheim-Chester disease More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Treatment Propionic acidaemia – Trials in Disease Choroid melanoma – Trials in Disease Acute respiratory distress syndrome – Life with Disease Leukoencephalopathy Choroid melanoma – Life with Disease Retinitis pigmentosa – Trials in Disease Haemolytic uraemic syndrome – Diagnostics X-linked lymphoproliferative syndrome – Basic Information Hepatic angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emtricitabine Vilobelimab Adalimumab ZILEBESIRAN Candesartan Cilexetil Rupatadine Human Cancellous Bone Montelukast Sodium Colesevelam Citicoline Sodium TRAZODONE HYDROCHLORIDE Tilmanocept Nanatinostat Revumenib Riliprubart Golcadomide Water For Injections Ursodeoxycholic Acid Vepdegestrant Gefurulimab More therapies…

    Learn about Your Condition

    Desmoid tumour Hip fracture Anal abscess Chronic hepatitis B Angelman's syndrome Inclusion body myositis Neoplasm malignant Polymyalgia rheumatica Renal disorder Gestational diabetes Invasive breast carcinoma Vulvovaginal pruritus Prolymphocytic leukaemia Sarcoidosis Angiosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Coronary artery disease

  • Study on Propofol and Remifentanil for Patients with Heart Disease Undergoing Cardiac Anesthesia with Cardiopulmonary Bypass

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic disorder
    • Cardiac valve disease
    • Coronary artery disease
    Investigated Drugs:
    • Remifentanil
    • Propofol
    Austria

  • Study on Dual Antiplatelet Therapy Duration for Patients with Chronic Coronary Artery Blockage Using Clopidogrel and D,L-Lysine Acetylsalicylate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • D,L-Lysine Acetylsalicylate
    • Clopidogrel
    France

  • Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

    Recruiting

    3 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Colchicine
    Belgium

  • Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Adenosine
    • Regadenoson
    • Syn2
    Finland Germany Italy The Netherlands Poland

  • Study Comparing Drug-Coated Balloon and Drug-Eluting Stents in Patients with Coronary Artery Disease at High Risk of Bleeding Using Acetylsalicylic Acid and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Prasugrel
    • Clopidogrel
    • Acetylsalicylic Acid
    Finland France Spain

  • Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    Investigated Drugs:
    • Adenosine
    • Regadenoson
    • Syn2
    Poland
Previous Page
1 2 3 4 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!